<Disease><Name>HYPERALDOSTERONISM, FAMILIAL, TYPE I; HALD1</Name><Synonym /><OMIM><Number>103900</Number><URL>http://omim.org/entry/103900</URL></OMIM><Orphanet><Number>403</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=403</URL></Orphanet><Protein><Number>Cytochrome P450 11B1, mitochondrial, Cytochrome P450 11B2, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/?query=database:(type:mim%20103900)&amp;sort=score</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>8q24.3</Gene><ICD>E26.0</ICD><Summary>rare;autosomal dominant</Summary><Symptoms><symtomp><id>2384</id><symptom>adrenal hyperplasia</symptom><category>ENDOCRINE SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1925</id><symptom>headache (severe, recurrent or occipital, migraine)</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>2296</id><symptom>hypertension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3502</id><symptom>hypokalemia / hypokalaemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2554</id><symptom>onset, fetus / fetal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3783</id><symptom>onset, variable age</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2139</id><name>Potassium</name><specimen>urine</specimen><value /><min>3.00</min><max>125.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>798</id><name>Aldosterone</name><specimen>plasma</specimen><value>increased</value><min>5.00</min><max>60.00</max><unit>ng/dl</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>799</id><name>Aldosterone</name><specimen>plasma</specimen><value>increased</value><min>1.00</min><max>160.00</max><unit>ng/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>410</id><name>Potassium</name><specimen>serum</specimen><value>normal/dec</value><min>3.90</min><max>5.90</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>411</id><name>Potassium</name><specimen>serum</specimen><value>normal/dec</value><min>3.50</min><max>5.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>412</id><name>Potassium</name><specimen>serum</specimen><value>normal/dec</value><min>3.50</min><max>5.50</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>5667</id><title>DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?</title><author>Lenders JWM,</author><journal>Eur J Endocrinol</journal><year>2018</year><book /><volume>178</volume><number>1</number><pages>R1-R9</pages><co_aut>et al.</co_aut></literature><literature><id>6174</id><title>Genetic Characterization of GnRH/LH- Responsive Primary Aldosteronism</title><author>Gagnon N,</author><journal>J Clin Endocrinol Metab</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6175</id><title>GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism</title><author>Monticone S,</author><journal>Eur J Endocrinol</journal><year>2018</year><book /><volume>178</volume><number>3</number><pages>R101-111</pages><co_aut>et al.</co_aut></literature><literature><id>5653</id><title>Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation&lt;/</title><author>Aglony M,</author><journal>Hypertension</journal><year>2011</year><book /><volume>57</volume><number>6</number><pages>1117-1121</pages><co_aut>et al.</co_aut></literature><literature><id>5654</id><title>Is familial hyperaldosteronism underdiagnosed in hypertensive children?</title><author>Mulatero P,</author><journal>Hypertension</journal><year>2011</year><book /><volume>57</volume><number>6</number><pages>1053-1055</pages><co_aut>et al.</co_aut></literature><literature><id>5666</id><title>Familial hyperaldosteronism I-III</title><author>Quack I,</author><journal>Horm Metab Res</journal><year>2010</year><book /><volume>42</volume><number>6</number><pages>424-428</pages><co_aut>Vonend O, Rump LC</co_aut></literature><literature><id>5652</id><title>Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree</title><author>Mulatero P,</author><journal>J Clin Endocrinol Metab</journal><year>2002</year><book /><volume>87</volume><number>7</number><pages>3187-3191</pages><co_aut>et al.</co_aut></literature><literature><id>5651</id><title>Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance</title><author>Stowasser M,</author><journal>J Clin Endocrinol Metab</journal><year>2000</year><book /><volume>85</volume><number>6</number><pages>2160-2166</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>